SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
NVST

Envista Holdings Corp (NVST)

NYSE: NVST · USD
Healthcare · Medical Instruments & Supplies
$23.27-$0.48 (-2.02%)
 
Market cap
$3.73B
Insider Score
Analyst consensus
Market Cap$3.73B+25.3%
Revenue (ttm)$2.88B
Net Income$633.60M
EPS$3.85
Shares Out160.34M
PE Ratio6.04
Forward PE13.91
Dividendn/a
Ex-Dividend Daten/a
Volume2,450,892
Open$23.75
Previous Close$23.75
Day's Range$23.02 - $23.76
52-Week Range$18.89 - $30.42
Beta0.94
AnalystsBuy
Price Target$28.92(+24.29%)
Earnings DateFeb 3, 2027

About NVST

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Address
Building E, Brea, CA, 92821-6208, United States
Market Cap
3.73 billion
Employees
12,000
Industrial Classification
Medical Instruments & Supplies

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$220.00K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Hold
3 Buy5 Hold0 SellAvg target $26.57 (+14.2%)

8 firms rating NVST in the last 3 months, one vote each. Issuer-paid research is not counted.

Next catalysts

1 Day
+0.21%
5 Days
-6.20%
1 Month
+3.40%
6 Months
-0.08%
1 Year
+25.33%

$NVST stock is featured in our Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of NVST by members of U.S. Congress

Pete SessionsHouse / RSale$1.00K – $15.00KJun 6, 2024

Recently reported changes in NVST holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by NVST's directors and management

Net Shares Purchased by Insiders−8k−4k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

NVST Estimated quarterly lobbying spending

Source: U.S. Senate LDA

NVST Revenue by Segment or Geography

$2.40BTotal
Corporate and other$1.20B49.79%
Operating profit$515.20M21.44%
Specialty Products & Technologies$443.70M18.46%
Equipment & Consumables$247.80M10.31%

As of: Q4 2026 (Oct 2, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New NVST patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to NVST from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from NVST’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
83
News & Sentiment
20% of score
58

News check: Q3 earnings beat with guidance raise outweighed by analyst downgrades; mixed business momentum signals underlying uncertainty.

Recent Insider Activity

Buys
0
Sells
1
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

SAEFSchwab Ariel ESG ETF1.77%
LSEQHarbor Long-Short Equity ETF (LSEQ)1.45%
XHEState Street SPDR S&P Health Care Equipment ETF1.42%
FHH.TOFirst Trust AlphaDEX U.S. Health Care Sector Index ETF0.94%
FXHFirst Trust Health Care AlphaDEX Fund0.94%
YUNGCorgi ETF Trust I - Longevity Consumer ETF0.94%
XMVMInvesco S&P MidCap Value with Momentum ETF0.92%
BRSMMFS Blended Research Small-Mid Cap ETF0.65%
RFVInvesco S&P MidCap 400 Pure Value ETF0.64%
DSMCDistillate Small/Mid Cash Flow ETF0.51%
SQLVRoyce Quant Small-Cap Quality Value ETF0.50%
IHIiShares U.S. Medical Devices ETF0.50%

Weight is the stock’s share of each fund’s holdings.